BD Announces Full Release of Medication Maximizing Syringe
FRANKLIN LAKES, N.J. -- BD (Becton, Dickinson and Company) today announced the full release of the safety-engineered BD Integra 1ml Retracting Tuberculin and Insulin Syringe, the latest addition to BD's Integra portfolio in the U.S. The BD Integra 1ml Retracting Syringes -- available in five needle/gauge sizes -- have an integral needle that can help clinicians maximize medications drawn from multi-dose vials.
"The BD Integra 1ml Syringe like all Integra syringes -- has extremely low waste space volume which helps to maximize the number of medication doses that can be drawn from a multi-dose medication vial," said Frank Guido, president of Medical Surgical Systems for BD Medical. "This feature can help healthcare providers and organizations reduce medication waste and the associated costs."
The BD Integra 1ml Syringe features a low waste space volume design. The permanently attached needle makes this reduction possible. The United States Pharmacopeia recommends that drug manufacturers overfill drug vials to account for the waste space volume typically found in conventional syringes. By using a syringe that minimizes waste space, clinicians can maximize the number of doses they draw from multi-dose vials. This benefit is especially important for physicians and healthcare facilities administering expensive medications.
The BD Integra 1ml Syringe is designed to help protect healthcare workers against accidental needlesticks while improving clinical performance and enhancing patient care. It is also designed to be activated using one hand, making it easier to use. The device also features wider flanges to offer healthcare workers more stability and comfort when delivering injections. The clear barrel and bold scale markings make precise dosing easier. In addition, after an injection is administered, the needle retracts into the syringe barrel, minimizing the potential for needlestick injury.
BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products
Source: BD
Pioneering Advances in Sterilization: The Future of Infection Control
November 28th 2024Germitec, STERIS, ASP, and Zuno Medical are pioneering sterilization advancements with groundbreaking technologies that enhance SPD workflows, improve patient safety, and redefine infection control standards.
Genomic Surveillance A New Frontier in Health Care Outbreak Detection
November 27th 2024According to new research, genomic surveillance is transforming health care-associated infection detection by identifying outbreaks earlier, enabling faster interventions, improving patient outcomes, and reducing costs.
Point-of-Care Engagement in Long-Term Care Decreasing Infections
November 26th 2024Get Well’s digital patient engagement platform decreases hospital-acquired infection rates by 31%, improves patient education, and fosters involvement in personalized care plans through real-time interaction tools.
Comprehensive Strategies in Wound Care: Insights From Madhavi Ponnapalli, MD
November 22nd 2024Madhavi Ponnapalli, MD, discusses effective wound care strategies, including debridement techniques, offloading modalities, appropriate dressing selection, compression therapy, and nutritional needs for optimal healing outcomes.
